Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

nasdaq:tenx

POPULAR ARTICLES

Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer

Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer

Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference

Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference

LATEST ARTICLES

Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026

Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026

Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment

Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment

Tenax Therapeutics to Participate in Upcoming Investor Conferences

Tenax Therapeutics to Participate in Upcoming Investor Conferences

Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Tenax Therapeutics to Host Virtual KOL Call to Discuss TNX-103 for the Treatment of PH-HFpEF

Tenax Therapeutics to Host Virtual KOL Call to Discuss TNX-103 for the Treatment of PH-HFpEF

Tenax Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

Tenax Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF

Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF

Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025

Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025

Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Tenax Therapeutics Inc.

Tenax Therapeutics Inc.

5 Top Pharmaceutical News Stories of 2019

pharmaceutical investing

5 Top Pharmaceutical News Stories of 2019

pharmaceutical investing

Tenax Therapeutics Updates on Phase 2 Pulmonary Trial

Latest News

Coelacanth Announces 2025 Year-End Reserves

REPEAT - Drilling at Swanson Gold Deposit Confirms Large-Scale Gold Discovery with 1.18 g/t Au over 255.04 metres and 1.65 g/t Au over 136.01 metres

Silver Dollar Extends Advertising and Investor Awareness Campaign with Investing News Network

Red Metal Completes LiDAR Analysis and Identifies New Exploration Targets

Miivo Expands Customer Base Across Healthcare, Legal, and Hospitality Sectors

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Lexaria Bioscience

Lexaria Bioscience (LEXX)

LEXX

GoldInxs Mining

GoldInxs Mining (None)

Aterian PLC

Aterian PLC (ATN:LN)

ATN:LN

Nuvau Minerals

Nuvau Minerals (NMC:CC)

NMC:CC

Spartan Metals

Spartan Metals (W:CC)

W:CC

Pinnacle Silver and Gold

Pinnacle Silver and Gold (PINN:CC)

PINN:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES